NEW YORK (GenomeWeb News) — Google has become a minority owner of early-stage personal genomics company 23andMe after investing $3.9 million as part of a Series A round of private-equity financing, Google said in a filing with the US Securities and Exchange Commission today.
 
Other investors in the round include Genentech, New Enterprise Associates, and MDV-Mohr Davidow Ventures. Genentech CEO Arthur Levinson is a Google director.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.